1
|
Weller HN, Rubin AE, Moshiri B, Ruediger W, Li WJ, Allen J, Nolfo J, Bertok A, Rosso VW. Development and Commercialization of the MiniBlock Synthesizer Family: A Historical Case Study. ACTA ACUST UNITED AC 2016. [DOI: 10.1016/j.jala.2004.07.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
An internal development project at Bristol-Myers Squibb (BMS) led to invention of a family of organic chemistry synthesis blocks for both parallel synthesis in drug discovery and parallel reaction optimization in pharmaceutical development. The internal demand for these synthesis blocks became so great that the original development team was challenged by the burden of ongoing manufacture, support, and supply chain management. As a result, BMS entered into a unique industry partnership with Mettler-Toledo AutoChem (MT), Newark, DE, formerly Bohdan Automation, to commercialize the reactor blocks and extend the product family, now known as the MiniBlock line. This manuscript describes the initial development drivers, the overall technical design, and the ultimate successful commercialization of the MiniBlock synthesis family.
Collapse
Affiliation(s)
- Harold N. Weller
- Bristol-Myers Squibb Company, Princeton, NJ and Mettler-Toledo AutoChem, Inc, Newark, DE
| | - A. Erik Rubin
- Bristol-Myers Squibb Company, Princeton, NJ and Mettler-Toledo AutoChem, Inc, Newark, DE
| | - Ben Moshiri
- Bristol-Myers Squibb Company, Princeton, NJ and Mettler-Toledo AutoChem, Inc, Newark, DE
- EDAX/AMETEk, Mahwah, NJ
| | - Walter Ruediger
- Bristol-Myers Squibb Company, Princeton, NJ and Mettler-Toledo AutoChem, Inc, Newark, DE
| | - Wen-Jeng Li
- Bristol-Myers Squibb Company, Princeton, NJ and Mettler-Toledo AutoChem, Inc, Newark, DE
| | - John Allen
- Bristol-Myers Squibb Company, Princeton, NJ and Mettler-Toledo AutoChem, Inc, Newark, DE
| | - Joseph Nolfo
- Bristol-Myers Squibb Company, Princeton, NJ and Mettler-Toledo AutoChem, Inc, Newark, DE
| | - Alexander Bertok
- Bristol-Myers Squibb Company, Princeton, NJ and Mettler-Toledo AutoChem, Inc, Newark, DE
| | - Victor W. Rosso
- Bristol-Myers Squibb Company, Princeton, NJ and Mettler-Toledo AutoChem, Inc, Newark, DE
| |
Collapse
|
2
|
Poma A, Guerreiro A, Whitcombe MJ, Piletska EV, Turner APF, Piletsky SA. Solid-Phase Synthesis of Molecularly Imprinted Polymer Nanoparticles with a Reusable Template - "Plastic Antibodies". ADVANCED FUNCTIONAL MATERIALS 2013; 23:2821-2827. [PMID: 26869870 PMCID: PMC4746745 DOI: 10.1002/adfm.201202397] [Citation(s) in RCA: 236] [Impact Index Per Article: 21.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
Molecularly Imprinted Polymers (MIPs) are generic alternatives to antibodies in sensors, diagnostics and separations. To displace biomolecules without radical changes in infrastructure in device manufacture, MIPs should share their characteristics (solubility, size, specificity and affinity, localized binding domain) whilst maintaining the advantages of MIPs (low-cost, short development time and high stability) hence the interest in MIP nanoparticles. Herein we report a reusable solid-phase template approach (fully compatible with automation) for the synthesis of MIP nanoparticles and their precise manufacture using a prototype automated UV photochemical reactor. Batches of nanoparticles (30-400 nm) with narrow size distributions imprinted with: melamine (d = 60 nm, Kd = 6.3 × 10-8 m), vancomycin (d = 250 nm, Kd = 3.4 × 10-9 m), a peptide (d = 350 nm, Kd = 4.8 × 10-8 m) and proteins have been produced. Our instrument uses a column packed with glass beads, bearing the template. Process parameters are under computer control, requiring minimal manual intervention. For the first time we demonstrate the reliable re-use of molecular templates in the synthesis of MIPs (≥ 30 batches of nanoMIPs without loss of performance). NanoMIPs are produced template-free and the solid-phase acts both as template and affinity separation medium.
Collapse
Affiliation(s)
- Alessandro Poma
- Cranfield Health, Vincent Building, Cranfield University, Cranfield, Bedfordshire, MK43 0AL (UK)
| | - Antonio Guerreiro
- Cranfield Health, Vincent Building, Cranfield University, Cranfield, Bedfordshire, MK43 0AL (UK)
| | - Michael J Whitcombe
- Cranfield Health, Vincent Building, Cranfield University, Cranfield, Bedfordshire, MK43 0AL (UK)
| | - Elena V Piletska
- Cranfield Health, Vincent Building, Cranfield University, Cranfield, Bedfordshire, MK43 0AL (UK)
| | - Anthony P F Turner
- Cranfield Health, Vincent Building, Cranfield University, Cranfield, Bedfordshire, MK43 0AL (UK)
| | - Sergey A Piletsky
- Cranfield Health, Vincent Building, Cranfield University, Cranfield, Bedfordshire, MK43 0AL (UK)
| |
Collapse
|